CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Deferred Tax Liabilities, Goodwill and Intangible Assets
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Deferred Tax Liabilities, Goodwill and Intangible Assets of $104.86 million as of 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets · last filed 2026-02-18
- 2025-12-27: Deferred Tax Liabilities, Goodwill and Intangible Assets $104.86M.
- 2024-12-28: Deferred Tax Liabilities, Goodwill and Intangible Assets $198.10M.
- 2023-12-30: Deferred Tax Liabilities, Goodwill and Intangible Assets $231.02M.
- 2022-12-31: Deferred Tax Liabilities, Goodwill and Intangible Assets $256.23M.
| Period end | Deferred Tax Liabilities, Goodwill and Intangible Assets |
|---|---|
| 2025-12-27 | $104.86M 10-K · filed 2026-02-18 |
| 2024-12-28 | $198.10M 10-K · filed 2026-02-18 |
| 2023-12-30 | $231.02M 10-K · filed 2025-02-19 |
| 2022-12-31 | $256.23M 10-K · filed 2024-02-14 |
| 2021-12-25 | $280.08M 10-K · filed 2023-02-22 |
| 2020-12-26 | $202.43M 10-K · filed 2022-02-16 |
| 2019-12-28 | $174.85M 10-K · filed 2021-02-17 |
| 2018-12-29 | $154.74M 10-K · filed 2020-02-11 |
| 2017-12-30 | $89.64M 10-K · filed 2019-02-13 |
| 2016-12-31 | $121.26M 10-K · filed 2018-02-13 |
| 2015-12-26 | $73.21M 10-K · filed 2017-02-14 |
| 2014-12-27 | $52.03M 10-K · filed 2016-02-12 |
| 2013-12-28 | $21.83M 10-K · filed 2015-02-17 |
| 2012-12-29 | $14.98M 10-K · filed 2014-02-25 |
| 2011-12-31 | $6.52M 10-K · filed 2013-02-27 |
| 2010-12-25 | $5.88M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |